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Abstract
Introduction: The association of thymoma with myasthenia gravis (MG) is well known. Thymoma
with sarcoidosis however, is very rare. We presented an interesting case with coexisting thymoma,
MG and sarcoidosis.
Case presentation: A 59-year-old female patient with a history of sarcoidosis was admitted to
the hospital with a one-day history of sudden onset of right-sided partial ptosis and diplopia.
Neurosarcoidosis with cranial nerve involvement was considered, but was ruled out by the clinical
findings, and MG was confirmed by the positive tensilon test, electrophysiological findings and
positive acetylcholine receptor binding antibodies. On further evaluation, a CT chest scan showed
a left anterior mediastinal mass and bilateral lymphadenopathy. Post surgical diagnosis confirmed
the thymoma and sarcoidosis in the lymph nodes.
Conclusion: When two or more diseases of undetermined origin are found together, several
interesting questions are raised. It is important to first confirm the diagnoses individually.
Immunologic mechanisms triggering the occurrence of these diagnoses together, are difficult to
address. Although the coexistence of thymoma, MG and sarcoidosis may be coincidental, it is
noteworthy to report this case because of the multiple interesting features observed as well as the
rarity of occurrence.
Introduction
The association of thymoma with myasthenia gravis (MG)
is well known and amply quoted [1,2]. Thymoma with
sarcoidosis however, is very rare [3]. Presented here is an
interesting case with coexisting thymoma, MG and sar-
coidosis.
Case Presentation
A 59-year-old female patient was admitted to the hospital
with a one-day history of sudden onset of right-sided par-
tial ptosis and diplopia on right lateral gaze. The patient
had generalized fatigue for over a year. At the age of 30,
the patient had symptoms of dyspnoea and painful nod-
ular swellings over her legs. During that time, sarcoidosis
was suspected and was confirmed by lung biopsy. For the
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The patient had occasional flares since then until a year
later, when she suffered from exacerbation of sarcoidosis
in the form of polyarthritis, generalized fatigue, dyspnoea,
fever and nodular swelling over legs. The patient again
declined steroids and chose to remain on naproxen. Her
symptoms had improved over a period of time except the
generalized fatigue. She also had diabetes mellitus diag-
nosed at the same time, which was well controlled with
metformin.
A neurological examination revealed a right-sided partial
ptosis, and compensatory pseudo- retraction of the left
eyelid (Figure 1a). Diplopia was noticed on right lateral
gaze due to right lateral rectus weakness. Fluctuations in
diplopia and ptosis were noticed during her hospital stay.
The patient did not have any bulbar symptoms like dys-
phagia or dysphonia. But she was having generalized
weakness in all her extremities, both proximal and distal,
with marked diurnal variation in the form of more weak-
ness during the evening.
During her hospital stay she developed respiratory distress
and hypoxemia. A chest CT scan demonstrated a 7 cm
necrotic mass in the left anterior mediastinum and bilat-
eral hilar lymphadenopathy (Figure 2). Pulmonary func-
tion tests revealed restrictive lung disease and moderately
decreased diffusion capacity. Steroids were recommended
for the active sarcoidosis, which the patient declined.
An ophthalmology consult revealed no evidence of uveitis
or optic neuritis. MG was confirmed by the tensilon test
that showed improvement in her ptosis (Figure 1b) and
strength in muscles of the upper limb. A confirmatory
electrophysiological study with repetitive nerve stimula-
tion (RNS) showed decrement in amplitude of action
potentials with further reduction post exercise and recov-
ery after 15 minutes, consistent with MG. Acetylcholine
receptor (AChR) binding antibodies were markedly ele-
vated (104.00 nmol/L; normal < 0.30), consistent with
MG.
The patient's corrected calcium level was mildly elevated
(10.7 mg/dl; normal 8.5–10.4). Other relevant tests with
respect to hypercalcemia were, normal renal function tests
(blood urea nitrogen 18 mg/dl, normal 7–25; creatinine
0.9 mg/dl, normal 0.7–1.4; phosphorous 3.9 mg/dl, nor-
mal 2.5–4.5; magnesium 1.8 mg/dl, 1.7–2.5) and normal
intact parathyroid hormone (PTH) levels (33 pg/ml, nor-
mal 10 – 69). Other tests like 1,25-dihydroxyvitamin D
(OHD), 25-hydroxyvitamin D and 24 hour urinary cal-
cium levels were not measured.
Further tests revealed a high sedimentation rate (ESR) (78
mm/hr; normal 0–30) and increased serum angiotensin
converting enzyme (ACE) levels (127 u/l, normal 9–67).
These results, in conjunction with the pulmonary func-
tion tests, and hilar lymphadenopathy were consistent
with active sarcoidosis.
Other relevant investigations including thyroid function
tests, muscle enzymes, anti nuclear antibodies, rheuma-
toid factor, B12 levels, glycosylated hemoglobin levels and
rapid plasma reagin tests were normal. MRI of the brain
was also normal.
A CT guided fine needle biopsy of the left anterior medi-
astinal mass showed a predominantly lymphocytic cytok-
eratin positive thymoma. The patient was started on
pyridostigmine with a remarkable improvement in weak-
ness, diplopia and ptosis. Surgical removal of the thy-
moma with lymphadenectomy was performed.
Postoperative surgical pathology demonstrated the pres-
ence of stage II A, WHO type B thymoma (Figure 3a).
Lymph nodes showed noncaseating granulomas with
a. Photograph of the patient showing right partial ptosis. The left lid shows compensatory pseudo lid retraction because of equal innervati n of the l vator palpabrae superioris (Herring's law)Figure 1
a. Photograph of the patient showing right partial ptosis. The left lid shows compensatory pseudo lid retraction 
because of equal innervation of the levator palpabrae superioris (Herring's law). b. Post tensilon test: Note the improvement in 
ptosis.
a bPage 2 of 4
(page number not for citation purposes)
Journal of Medical Case Reports 2008, 2:245 http://www.jmedicalcasereports.com/content/2/1/245multinucleated giant cells confirming sarcoidosis (Figure
3b).
The patient was diagnosed with having coexistent thy-
moma, MG and sarcoidosis.
The patient underwent post thymectomy radiotherapy.
After successful counseling she was also started on a high
dose of oral prednisone and oral pyridostigmine was con-
tinued. She has remained asymptomatic to date, and oral
prednisone is being tapered accordingly.
Discussion
Coexistence of thymoma, MG and sarcoidosis is very rare.
A literature review revealed documentation of thymoma
with sarcoidosis in two cases [3], and MG with sarcoidosis
in two cases [4]. The presence of thymoma, MG and sar-
coidosis together has not been discussed previously,
except a single case mentioned in a MG case series without
any detailed discussion [5].
Neurosarcoidosis is a complication in 5% of patients with
sarcoidosis [6]. The most common neurological manifes-
tations of sarcoidosis are cranial neuropathies from
chronic basal meningitis. The facial nerve is affected most
often, sometimes bilaterally. Optic nerve may also be
swollen or atrophied. Ophthalmologic examination in
our patient revealed normal fundus, normal 3rd, 4th and
6th cranial nerve examination and no evidence of uveitis.
Other cranial nerve examinations were normal. MRI brain
did not show any evidence of sarcoidosis. All these fea-
tures suggested the low probability of neurosarcoidosis.
Hypercalcemia in patients with thymoma can be seen due
to the following reasons, namely, secretion of parathy-
CT chest image revealing large necrotic mass in the left ante-rior m diastinum and bilate al hilar lymphadenopathyFigur  2
CT chest image revealing large necrotic mass in the 
left anterior mediastinum and bilateral hilar lym-
phadenopathy.
a. Mass from the anterior mediastinum confirming thymoma B1 WHO type, lymphocyte rich predominantly corticalFigure 3
a. Mass from the anterior mediastinum confirming thymoma B1 WHO type, lymphocyte rich predominantly 
cortical. (H&E stain, high magnification). b. Biopsy from the lymph nodes showing multiple non-caseating granulomas 
with multinucleated giant cells and histiocytes (H&E stain, low magnification).
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roid-related protein (PTHrP) or PTH by the thymoma
itself, coexistence of parathyroid adenoma or hyperplasia
of parathyroid gland [7]. In these cases, PTH level is usu-
ally elevated. Hypercalcemia can occur in granuloma
forming disorders such as sarcoidosis, because of extra
renal production of 1,25-dihydroxyvitamin D. PTH
release is inhibited by hypercalcemia and high levels of
calcitriol, which explains the suppressed PTH level in sar-
coidosis [8]. In our patient the PTH level was inappropri-
ately normal, which cannot exclude coexisting
hyperparathyroidism. Other tests like 1,25-dihydroxyvita-
min D, 25-hydroxyvitamin D, 24-hour urinary calcium
levels and immunohistochemistry for PTH, would have
been appropriate evaluation tests in the current case.
Approximately 30–50% of patients with thymoma have
MG [1]. The symptoms of MG usually precede the discov-
ery of a thymoma. Reports indicate the association of MG
with thymoma to be about 15% but increase to 35% in
older patients [2]. Ocular symptoms like diplopia and
ptosis are the commonest clinical presentations in MG
seen in more than 50% of patients [1]. Positive tensilon
and RNS tests have sensitivities of 70 and 75% respec-
tively [9]. AChR antibodies are elevated in 98% of patients
with MG and thymoma [9]. The reported case has all these
findings.
It is well known that disorders of immune response may
coexist in some patients [10]. When two or more diseases
of undetermined origin are found together, several inter-
esting questions are raised. It is important to first confirm
the diagnoses individually. Immunologic mechanisms
triggering the occurrence of these diagnoses together, is
difficult to address. Thyroid and autoimmune diseases are
often observed in these cases. This patient however had
normal thyroid and autoimmune profiles. Although the
coexistence of thymoma, MG and sarcoidosis may be
coincidental, it is noteworthy to report this case because
of the multiple interesting features observed as well as the
rarity of occurrence.
Conclusion
In this case sudden onset of ptosis and diplopia was noted
in a sarcoidosis patient. This could have been neurosar-
coidosis with cranial nerve manifestation. But, this case
revealed an unusual presentation of thymoma and MG
and their rare association with sarcoidosis.
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